These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239 [TBL] [Abstract][Full Text] [Related]
6. A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung. Masters GA; Hoffman PC; Drinkard LC; Samuels BL; Golomb HM; Vokes EE Semin Oncol; 1998 Feb; 25(1 Suppl 2):8-14. PubMed ID: 9535205 [TBL] [Abstract][Full Text] [Related]
7. A phase I/phase II trial of granulocyte colony-stimulating factor as bone marrow support in patients treated with vinorelbine (Navelbine): study design and goals. Havlin K Semin Oncol; 1995 Apr; 22(2 Suppl 5):38-40; discussion 41-4. PubMed ID: 7537912 [TBL] [Abstract][Full Text] [Related]
9. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer. Chang AY; DeVore R; Johnson D Semin Oncol; 1996 Apr; 23(2 Suppl 5):19-21. PubMed ID: 8610231 [TBL] [Abstract][Full Text] [Related]
10. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237 [TBL] [Abstract][Full Text] [Related]
11. A pilot study with cisplatin, ifosfamide and weekly administration of vinorelbine as an outpatient combination chemotherapy for advanced non small cell lung cancer. Tibaldi C; Baldini E; Ricci S; Conte PF Anticancer Res; 1996; 16(5B):3213-5. PubMed ID: 8920792 [TBL] [Abstract][Full Text] [Related]
12. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490 [TBL] [Abstract][Full Text] [Related]
13. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer. Chang AY; Garrow GC Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336 [TBL] [Abstract][Full Text] [Related]
14. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766 [TBL] [Abstract][Full Text] [Related]
15. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154 [TBL] [Abstract][Full Text] [Related]
16. Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer. Viallet J; Ayoub J; Rousseau P; Souhami L; Hohneker J; Shepherd F Semin Oncol; 1994 Oct; 21(5 Suppl 10):64-71; discussion 71-2. PubMed ID: 7973771 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. Hoffman PC; Krauss SA; Drinkard LC; Masters GA; Samuels BL; Bitran JD; Golomb HM; Watson S; Vokes EE Semin Oncol; 1995 Aug; 22(4 Suppl 9):38-41. PubMed ID: 7544026 [TBL] [Abstract][Full Text] [Related]
18. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer. Shepherd FA; Latreille J; Paul K; Eisenhauer E Semin Oncol; 1996 Dec; 23(6 Suppl 16):84-90. PubMed ID: 9007130 [TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer. Clarke SJ; Boyer MJ; Millward M; Underhill C; Moylan E; Yip D; White S; Childs A; Beale P; Latz J; Suri A; Iglesias JL Lung Cancer; 2005 Sep; 49(3):401-12. PubMed ID: 15923057 [TBL] [Abstract][Full Text] [Related]
20. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]